Below is Validea's guru fundamental report for MCKESSON CORP (MCK). Of the 22 guru strategies we follow, MCK rates highest using our Multi-Factor Investor model based on the published strategy of ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

McKesson (NYSE:MCK) is one of the three main drug distribution firms in the United States. The company has more than 50,000 employees and generates around $350 billion in annual revenues ...

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against Larry Robbins' other long-term stock picks. Larry Robbins is an American hedge fund manager ...

McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow, despite recent price increases and solid growth prospects in oncology and GLP-1 medications ...

McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic about the company’s performance in 2025. MCK’s growth this year ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

The majority owner of New Zealand hotel company Millennium & Copthorne Hotels (MCK) is proposing a full takeover of the remaining shares in the company. CDL Hotels Holdings New Zealand, owned by ...